Medicines labeled for the same conditions
Alternatives to fluticasone and umeclidinium and vilanterol
20 other medicines are given the same way (respiratory (inhalation)) and in the same FDA class as fluticasone and umeclidinium and vilanterol or labeled mainly for the same use (COPD); 19 are in its class, beta2-adrenergic agonists: albuterol, budesonide, albuterol and ipratropium, budesonide and formoterol and 15 more; the others include 1 phosphodiesterase 3 inhibitor (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.0612 per mL (Albuterol sul 2.5 mg/3 mL solution) (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as fluticasone and umeclidinium and vilanterol?
COPD lists all 23 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (respiratory (inhalation)) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Fluticasone and umeclidinium and vilanterolbeta2-adrenergic agonist | this medicine | none listed | $11.12 per unit 100-62.5-25 | No | No current entry |
| Albuterolbeta2-adrenergic agonist · same class | Asthma | 33 labelers | $0.0612 per mL 2.5 mg/3 mL solution | No | Resolved |
| Budesonidecorticosteroid · same class | Asthma | 13 labelers | $0.676 per mL 0.5 mg/2 mL suspension | No | No current entry |
| Albuterol and ipratropiumbeta2-adrenergic agonist · same class | COPD | 14 labelers | $0.0787 per mL 0.5-3(2.5) mg/3 mL | No | No current entry |
| Budesonide and formoterolbeta2-adrenergic agonist · same class | Asthma, COPD | 2 labelers | $17.26 per gram 160-4.5 | No | No current entry |
| Ipratropiumanticholinergic · same class | COPD | 13 labelers | $0.111 per mL 0.02% solution | No | No current entry |
| Arformoterolbeta2-adrenergic agonist · same class | COPD | 15 labelers | $0.633 per mL 15 mcg/2 mL solution | No | No current entry |
| Formoterolbeta2-adrenergic agonist · same class | COPD | 11 labelers | $1.30 per mL 20 mcg/2 mL neb vial | No | No current entry |
| Beclomethasonecorticosteroid · same class | Asthma | 2 labelers | $20.57 per gram 40 mcg | No | No current entry |
| Mometasonecorticosteroid · same class | Asthma | none listed | $6.84 per gram 50 mcg inhaler | No | No current entry |
| Formoterol and mometasonebeta2-adrenergic agonist · same class | Asthma | none listed | $25.22 per gram 100 mcg-5 mcg inhaler | No | No current entry |
| Budesonide and formoterol and glycopyrrolatecholinergic muscarinic antagonist · same class | Asthma, COPD | none listed | $61.41 per gram 160-9-4.8 mcg | No | No current entry |
| Tiotropiumanticholinergic · same class | Asthma, COPD | none listed | $126.08 per gram 1.25 mcg inhaler | No | No current entry |
| Aclidiniumanticholinergic · same class | COPD | none listed | $344.55 per unit 400 mcg inhal | No | No current entry |
| Aclidinium and formoterolbeta2-adrenergic agonist · same class | COPD | none listed | n/a | No | No current entry |
| Albuterol and budesonidebeta2-adrenergic agonist · same class | Asthma | none listed | $45.03 per gram 90-80 mcg inhaler | No | No current entry |
| Formoterol and glycopyrrolatecholinergic muscarinic antagonist · same class | COPD | none listed | $40.86 per gram Bevespi aerosphere inhaler | No | No current entry |
| Olodaterolbeta2-adrenergic agonist · same class | COPD | none listed | $65.94 per gram Striverdi respimat inhal spray | No | No current entry |
| Olodaterol and tiotropiumbeta2-adrenergic agonist · same class | COPD | none listed | $115.80 per gram 60) | No | No current entry |
| Revefenacinanticholinergic · same class | COPD | none listed | $17.43 per mL 175 mcg/3 mL solution | No | No current entry |
| Ensifentrinephosphodiesterase 3 inhibitor | COPD | none listed | n/a | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Fluticasone and umeclidinium and vilanterol: the full record
- label, generics, price, shortages, recalls